Single-cell sequencing revealed that ACSL3 is primarily concentrated in hepatocytes, implying its potential role in facilitating the transition from NAFLD to HCC by modulating hepatic lipid metabolism. This evidence concerns the gene ACSL3 and metabolic dysfunction-associated steatotic liver disease.